Merck Financial Statements From 2010 to 2024

MRK Stock  USD 121.44  0.08  0.07%   
Merck financial statements provide useful quarterly and yearly information to potential Merck Company investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Merck financial statements helps investors assess Merck's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Merck's valuation are summarized below:
Gross Profit
42.1 B
Profit Margin
0.0061
Market Capitalization
307.8 B
Enterprise Value Revenue
5.5848
Revenue
60.1 B
There are currently one hundred twenty fundamental ratios for Merck that can be evaluated and compared over time across peers in the industry. We recommend to check Merck's last-minute fundamental drivers against the all of the trends between 2010 and 2024.
Check Merck financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.8 B, Interest Expense of 1.2 B or Total Revenue of 32.5 B, as well as many exotic indicators such as Short Term Coverage Ratios of 5.95, Price Earnings Ratio of 799 or Price To Sales Ratio of 4.31. Merck financial statements analysis is a perfect complement when working with Merck Valuation or Volatility modules.
  
This module can also supplement Merck's financial leverage analysis and stock options assessment as well as various Merck Technical models . Check out the analysis of Merck Correlation against competitors.

Merck Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets60.3 B106.7 B89.7 B
Pretty Stable
Short and Long Term Debt Total38.1 B36.3 B25.5 B
Slightly volatile
Other Current Liabilities16.3 B15.5 B13.4 B
Slightly volatile
Total Current Liabilities13.3 B25.7 B19.1 B
Slightly volatile
Total Stockholder Equity25.5 B37.6 B36.9 B
Pretty Stable
Property Plant And Equipment Net25.7 B24.5 B15.8 B
Slightly volatile
Retained Earnings32.6 B53.9 B42.4 B
Slightly volatile
Cash5.6 B6.9 B8.7 B
Pretty Stable
Non Current Assets Total41.1 B74.5 B61.5 B
Pretty Stable
Cash And Short Term Investments7.3 B7.2 B11 B
Slightly volatile
Net Receivables11.6 B11.1 B7.6 B
Slightly volatile
Common Stock Shares Outstanding2.7 B2.5 B2.7 B
Slightly volatile
Liabilities And Stockholders Equity60.3 B106.7 B89.7 B
Pretty Stable
Non Current Liabilities Total45.5 B43.3 B34.8 B
Slightly volatile
Inventory3.7 B6.4 B5.3 B
Pretty Stable
Other Current AssetsB7.6 B5.1 B
Slightly volatile
Total Liabilities72.5 B69 B54.8 B
Slightly volatile
Total Current Assets19.2 B32.2 B28.2 B
Pretty Stable
Short Term Debt2.3 B1.7 B2.9 B
Very volatile
Intangible Assets14.3 B18 B18.5 B
Pretty Stable
Accounts Payable2.8 B3.9 BB
Slightly volatile
Property Plant And Equipment Gross43.4 B41.3 B20.7 B
Slightly volatile
Common Stock Total Equity1.2 B2.1 B1.6 B
Slightly volatile
Common Stock1.2 B2.1 B1.6 B
Slightly volatile
Other Liabilities10.2 B10.5 B10.9 B
Slightly volatile
Other Assets5.5 B8.5 BB
Slightly volatile
Long Term Debt17.2 B33.7 B21.5 B
Slightly volatile
Good Will12.3 B21.2 B16.1 B
Slightly volatile
Property Plant Equipment16.2 B24.6 B15.8 B
Slightly volatile
Current Deferred Revenue6.6 B5.3 B2.3 B
Slightly volatile
Long Term Debt Total23.6 B33.1 B22.6 B
Slightly volatile
Capital Surpluse44.7 B51 B41.6 B
Slightly volatile
Long Term Investments239.4 M252 M5.7 B
Slightly volatile
Short and Long Term Debt1.3 B1.4 B2.2 B
Slightly volatile
Non Current Liabilities Other10.8 B8.8 B9.3 B
Slightly volatile
Cash And Equivalents9.3 B14.6 B8.1 B
Slightly volatile
Net Invested Capital69.2 B72.6 B61.4 B
Slightly volatile
Net Working Capital6.3 B6.5 B5.9 B
Very volatile
Capital Stock1.4 B1.6 B1.8 B
Slightly volatile

Merck Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.8 B3.9 B4.7 B
Slightly volatile
Total Revenue32.5 B59.9 B42.8 B
Slightly volatile
Gross Profit46.1 B43.9 B30.4 B
Slightly volatile
Other Operating Expenses59.7 B56.9 B36.5 B
Slightly volatile
Operating Income2.8 BB7.3 B
Very volatile
EBIT5.4 BB5.6 B
Slightly volatile
EBITDA8.2 B6.9 B10.3 B
Pretty Stable
Cost Of Revenue11.7 B16 B14.1 B
Pretty Stable
Total Operating Expenses43 B40.9 B22 B
Slightly volatile
Income Before Tax1.8 B1.9 B8.2 B
Very volatile
Net Income346.8 M365 M6.3 B
Pretty Stable
Income Tax ExpenseB1.5 BB
Very volatile
Research Development32.1 B30.5 B11.9 B
Slightly volatile
Selling General Administrative8.9 B10.4 B9.7 B
Pretty Stable
Net Income Applicable To Common Shares17.5 B16.7 B8.8 B
Slightly volatile
Net Income From Continuing OpsB4.6 B7.7 B
Very volatile
Non Recurring288.1 M303.3 M787.3 M
Slightly volatile
Selling And Marketing Expenses1.9 BBB
Slightly volatile
Tax Provision2.2 B2.8 B1.7 B
Slightly volatile
Interest Income732.6 M390 M776.1 M
Pretty Stable
Reconciled Depreciation3.1 B3.8 B4.2 B
Slightly volatile
Discontinued Operations563.2 M633.6 M689.9 M
Slightly volatile

Merck Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow6.7 B9.1 B8.3 B
Slightly volatile
Begin Period Cash Flow13.4 B12.8 B9.6 B
Pretty Stable
Depreciation3.1 B3.9 B4.7 B
Slightly volatile
Dividends PaidB7.4 B5.3 B
Slightly volatile
Capital Expenditures2.2 B3.9 B2.6 B
Slightly volatile
Total Cash From Operating Activities8.8 B13 B10.8 B
Slightly volatile
Net Income346.8 M365 M6.1 B
Very volatile
End Period Cash Flow6.2 B6.9 B8.8 B
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Short Term Coverage Ratios5.957.84915.3511
Pretty Stable
Price Earnings Ratio799761126
Slightly volatile
Price To Sales Ratio4.314.63793.7644
Slightly volatile
Dividend Yield0.02460.02680.0321
Slightly volatile
Operating Cycle227213206
Very volatile
Price Book Value Ratio6.927.38874.9501
Slightly volatile
Days Of Payables Outstanding12289.599493.2814
Very volatile
Operating Cash Flow Per Share2.565.10643.9604
Slightly volatile
Dividend Payout Ratio21.4220.39733.5191
Slightly volatile
Price To Operating Cash Flows Ratio18.1221.349716.273
Slightly volatile
Free Cash Flow Per Share1.933.58973.0084
Slightly volatile
Price To Free Cash Flows Ratio25.9730.370122.4559
Slightly volatile
Pretax Profit Margin0.030.03160.1917
Pretty Stable
Inventory Turnover3.452.51292.6654
Pretty Stable
Ebt Per Ebit0.940.63351.1195
Very volatile
Payables Turnover4.284.07374.8712
Slightly volatile
Operating Profit Margin0.04730.04980.1717
Slightly volatile
Effective Tax Rate0.840.80040.3188
Slightly volatile
Company Equity Multiplier1.92.83852.4668
Slightly volatile
Long Term Debt To Capitalization0.50.47270.3595
Slightly volatile
Cash Per Share2.082.81153.9397
Pretty Stable
Total Debt To Capitalization0.510.48460.3932
Slightly volatile
Interest Coverage2.472.60219.6624
Slightly volatile
Return On Capital Employed0.0350.03680.1095
Slightly volatile
Payout Ratio21.4220.39733.5191
Slightly volatile
Debt Equity Ratio0.990.94040.6963
Slightly volatile
Ebit Per Revenue0.04730.04980.1717
Slightly volatile
Quick Ratio1.060.70961.0218
Slightly volatile
Dividend Paid And Capex Coverage Ratio3.813.63094.3765
Slightly volatile
Net Income Per E B T0.180.19320.6818
Slightly volatile
Cash Ratio0.330.26890.4825
Slightly volatile
Cash Conversion Cycle85.18123129
Slightly volatile
Operating Cash Flow Sales Ratio0.20.21720.2437
Pretty Stable
Days Of Inventory Outstanding159145143
Very volatile
Days Of Sales Outstanding67.3367.499863.3509
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.580.7030.7437
Slightly volatile
Cash Flow Coverage Ratios0.350.3680.6208
Slightly volatile
Price To Book Ratio6.927.38874.9501
Slightly volatile
Current Ratio1.621.2521.5546
Slightly volatile
Fixed Asset Turnover2.172.44492.8334
Pretty Stable
Price Cash Flow Ratio18.1221.349716.273
Slightly volatile
Enterprise Value Multiple47.0444.796220.3829
Slightly volatile
Debt Ratio0.350.33130.2637
Slightly volatile
Cash Flow To Debt Ratio0.350.3680.6208
Slightly volatile
Price Sales Ratio4.314.63793.7644
Slightly volatile
Return On Assets0.00330.00340.0707
Pretty Stable
Receivables Turnover4.985.40745.8086
Very volatile
Asset Turnover0.730.56120.508
Slightly volatile
Net Profit Margin0.00580.00610.1436
Pretty Stable
Gross Profit Margin0.740.73310.6748
Slightly volatile
Price Fair Value6.927.38874.9501
Slightly volatile
Return On Equity0.00920.00970.1776
Very volatile

Merck Fundamental Market Drivers

Forward Price Earnings14.1643
Cash And Short Term Investments7.2 B

Merck Upcoming Events

25th of April 2024
Upcoming Quarterly Report
View
6th of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
6th of February 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

About Merck Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Merck income statement, its balance sheet, and the statement of cash flows. Merck investors use historical funamental indicators, such as Merck's revenue or net income, to determine how well the company is positioned to perform in the future. Although Merck investors may use each financial statement separately, they are all related. The changes in Merck's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Merck's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Merck Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Merck. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue5.3 B6.6 B
Total Revenue59.9 B32.5 B
Cost Of Revenue16 B11.7 B
Ebit Per Revenue 0.05  0.05 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Global Correlations
Find global opportunities by holding instruments from different markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.453
Dividend Share
2.92
Earnings Share
0.15
Revenue Per Share
23.695
Quarterly Revenue Growth
0.058
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.